Human Antithrombin III(Sichuan Yuanda Shuyang Pharma)

人抗凝血酶Ⅲ(四川远大蜀阳)

Report date: 2024/12/09 20:01:07

Base Information

Drug NameHuman Antithrombin III(Sichuan Yuanda Shuyang Pharma)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor X inhibitorsThrombin inhibitorsAntithrombin-III replacements
TargetsCoagulation factor XProthrombin
Therapy Area/IndicationsAntithrombin III DeficiencyThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYuanda Shuyang Life Sciences (Chengdu) Co Ltd
Inactive CompaniesN/A
Active IndicationsAntithrombin III DeficiencyThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A